Molecule Information
General Information of the Molecule (ID: Mol03000)
Type(s) of Resistant Mechanism of This Molecule
EADR: Epigenetic Alteration of DNA, RNA or Protein
Drug Resistance Data Categorized by Drug
Approved Drug(s)
1 drug(s) in total
Cisplatin
Drug Sensitivity Data Categorized by Their Corresponding Mechanisms | ||||
Epigenetic Alteration of DNA, RNA or Protein (EADR) | ||||
Disease Class: Glioblastoma | [1] | |||
Sensitive Disease | Glioblastoma [ICD-11: 2A00.02] | |||
Sensitive Drug | Cisplatin | |||
Molecule Alteration | Expression | Up-regulation |
||
Experimental Note | Revealed Based on the Cell Line Data | |||
Cell Pathway Regulation | miR26a/GSk3Beta/Mcl1 signaling pathway | Regulation | hsa05206 | |
In Vitro Model | U251-MG cells | Brain | Homo sapiens (Human) | CVCL_0021 |
U87MG cells | Brain | Homo sapiens (Human) | CVCL_GP63 | |
Experiment for Molecule Alteration |
qRT-PCR | |||
Experiment for Drug Resistance |
MTT assay; Annexin V-FITC staining assay; Flow cytometry assay | |||
Mechanism Description | AC023115.3 sensitized glioma cell to cisplatin-induced apoptosis through regulation of the miR26a-GSk3beta-Mcl1 signalling. AC023115.3 acted as a miR26a sponge and inhibited its activity, thus increased the expression of GSk3beta. |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Sun and Dr. Zhang.